About Ashland Inc.
https://www.ashland.comAshland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments.

CEO
Guillermo Novo
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2017-05-15 | Forward | 511:250 |
| 2005-07-01 | Forward | 2500:2053 |
ETFs Holding This Stock
Summary
Showing Top 3 of 180
Ratings Snapshot
Rating : C
Most Recent Analyst Grades

Argus Research
Buy

UBS
Buy

Mizuho
Outperform

BMO Capital
Outperform

JP Morgan
Overweight

Wells Fargo
Equal Weight
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership

VANGUARD GROUP INC
Shares:4.61M
Value:$297.72M

BLACKROCK INC.
Shares:4.47M
Value:$288.89M

BLACKROCK, INC.
Shares:4.27M
Value:$275.85M
Summary
Showing Top 3 of 456
About Ashland Inc.
https://www.ashland.comAshland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $478M ▲ | $98M ▼ | $32M ▲ | 6.69% ▲ | $0.72 ▲ | $130M ▲ |
| Q3-2025 | $463M ▼ | $840M ▲ | $-742M ▼ | -160.26% ▼ | $-16.13 ▼ | $-613M ▼ |
| Q2-2025 | $479M ▲ | $96M ▼ | $31M ▲ | 6.47% ▲ | $0.68 ▲ | $114M ▲ |
| Q1-2025 | $405M ▼ | $290M ▲ | $-165M ▼ | -40.74% ▼ | $-3.5 ▼ | $-143M ▼ |
| Q4-2024 | $522M | $143M | $16M | 3.07% | $0.34 | $93M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $207M | $4.62B | $2.73B | $1.89B |
| Q3-2025 | $207M ▲ | $4.62B ▼ | $2.73B ▲ | $1.89B ▼ |
| Q2-2025 | $168M ▼ | $5.23B ▲ | $2.67B ▲ | $2.56B ▼ |
| Q1-2025 | $219M ▼ | $5.23B ▼ | $2.64B ▼ | $2.59B ▼ |
| Q4-2024 | $300M | $5.64B | $2.78B | $2.87B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-741M ▼ | $106M ▼ | $1M ▲ | $-70M | $39M | $86M ▼ |
| Q3-2025 | $-719M ▼ | $133M ▲ | $-63M ▼ | $-70M ▼ | $39M ▲ | $113M ▲ |
| Q2-2025 | $31M ▲ | $1M ▲ | $17M ▲ | $-69M ▼ | $-51M ▲ | $-20M ▲ |
| Q1-2025 | $-165M ▼ | $-40M ▼ | $-18M ▼ | $-22M ▲ | $-81M ▲ | $-63M ▼ |
| Q4-2024 | $16M | $67M | $3M | $-169M | $-99M | $29M |
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Intermediates And Solvents | $30.00M ▲ | $40.00M ▲ | $40.00M ▲ | $70.00M ▲ |
Life Sciences | $200.00M ▲ | $220.00M ▲ | $200.00M ▼ | $390.00M ▲ |
Personal Care And Household | $130.00M ▲ | $170.00M ▲ | $170.00M ▲ | $340.00M ▲ |
Specialty Additives | $120.00M ▲ | $160.00M ▲ | $150.00M ▼ | $290.00M ▲ |

CEO
Guillermo Novo
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2017-05-15 | Forward | 511:250 |
| 2005-07-01 | Forward | 2500:2053 |
ETFs Holding This Stock
Summary
Showing Top 3 of 180
Ratings Snapshot
Rating : C
Most Recent Analyst Grades

Argus Research
Buy

UBS
Buy

Mizuho
Outperform

BMO Capital
Outperform

JP Morgan
Overweight

Wells Fargo
Equal Weight
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership

VANGUARD GROUP INC
Shares:4.61M
Value:$297.72M

BLACKROCK INC.
Shares:4.47M
Value:$288.89M

BLACKROCK, INC.
Shares:4.27M
Value:$275.85M
Summary
Showing Top 3 of 456




